<p><i><strong>Individuals with a high polygenic risk are likely to derive the most benefit from lifestyle change and/or therapeutic intervention</strong></i></p>

Principle Diagnostics Celebrates 10 Years of Excellence

Agreement is DEMECAN's first to add international genetics to its collection

Coronary Heart Disease (CHD) prevention nearly twice as effective when using CARDIO inCode
as method to target treatment

The Vilcek Prizes for Creative Promise recognize rising immigrant scientists living and working in the United States whose work represents a significant contribution to their field.

Born in Venezuela, developmental and molecular biologist Alejandro Sánchez Alvarado receives the $100,000 prize for his contributions to the field of regeneration.

▪ Since 2019, CRAG and IRTA have been collaborating on a research project for the genetic improvement of cannabis plants with Front Range Biosciences under authorization of the Spanish Agency of Medicine and Medical Devices (AEMPS)
▪ The aim of the project is to develop innovative tools allowing for the creation of new varieties of cannabis
▪ The partnership leverages the expertise and capabilities of the involved institutions to strengthen research and accelerate the development of innovative solutions for high-value crops

Lipid inCode® offers greater diagnostic information for hypercholesterolemia sufferers over current NHS standard

LifeBank Chain (LBC) focuses on genetics and cell research, with the purposes of furthering human longevity and expanding access to genetics and cell treatments.

Commencement of regulatory pathway for U.S. market approval

Swiss Life Sciences Group Plc (SLSG) is pleased to announce its partnership with Switzerland's leading cannabis and CBD genetics experts, Bio Zu Farm.

Pilot program brings genetic tools and education to patients searching for answers tied to their chronic medical conditions in Taiwan, Mexico, Argentina, Brazil, Turkey, and Russia

From the comfort of one's home, individuals can order and receive all the materials for Baylor Genetics' at-home test for COVID-19. The results of the test will notify individuals if they are currently infected with SARS-CoV-2 virus within 24 - 48 hours.

The country's leading expert in pharmacogenetics teams up with Pharmazam, helping American's get answers regarding their unique genetic makeup and how it relates to optimizing their own healthcare during a pandemic.

Accurate Diagnostic Laboratories and RUCDR Infinite Biologics through its Clinical Genomics Laboratory are pleased to announce they have implemented a test that will allow virtually anyone to test for COVID-19.

What did our 70,000-year old ancestors really look like? Genetics lends us insights.

Revolutionary Pharmazam Physician-Ordered Personalized Real-Time Healthcare System Gifted to 2020 Acting and Director Oscar® Nominees in 'Everyone Wins' Goodie Bag

Authors Ask: Did Our Human Ancestors Gain Their Earliest Technological Advances from Denisovans with Savant Skills?

Matching an Individual's Medications Instantly to Drug-to-Drug, Illness, Food, Known Allergies, Lifestyle Choices and Their OWN Unique Genetic (DNA) Profile

This new approach to genomic data will provide new insights to individuals for diseases such as cancers, epilepsy, diabetes, Alzheimer's, Parkinson's disease and other rare diseases. People in all countries will be able to benefit from Dante Labs AI.

Dante Labs introduced 30x long reads whole genome sequencing based on Oxford Nanopore technology. This is the first long reads whole genome available commercially worldwide. Sequencing will be performed at Dante Labs' new highly automated, certified third-generation sequencing center in L'Aquila, Italy.

Dante Labs takes the first step of its ambitious project to integrate high coverage genome sequencing in clinical care in clinics and hospitals.

The Color-Sayre partnership will provide a fully integrated solution for patients and providers by delivering actionable clinical test results at an accessible price point.

It's in Our Drone

According to the new market research report launched by Inkwood Research, The Global CRISPR Market was valued around $ 500 million in 2017 and is anticipated to reach 8000 million by 2026, growing at an estimated CAGR of 36.53%, during the forecast period 2018-2026.

Partnership combines local support with global capabilities to deliver affordable tests to identify genetic mutations associated with an increased risk for hereditary cancer and inherited heart conditions for which early knowledge can make a difference.

The Ehlers-Danlos Society Seeks to Build Awareness Among Dancers, Gymnasts, and Acrobats

DNA industry experts help consumers make best decision this holiday season with unbiased analysis of the leading DNA test companies

Strand NGS now supports large scale RNA- and small-RNA-Seq and Unique Molecular Identifiers (UMIs) for DNA-, RNA-, and small-RNA-Seq.

Children of Vietnam Veterans Alliance Inc. to gather environmental and veteran affairs experts and activists from around the world

BABYGlimpse, a new app available on the Helix marketplace, explores over 20 different traits, including ancestry, physical appearance, and wellness-related traits

Bringing mental health professionals and genetic scientists together.

New genetic study aims to enroll 50,000 individuals with autism and their families.